To issue task A06 - listeria monocytogenes MIC determination
Ended Awarded Last action
- Contract number
- 75N93019F00132
- Awardee
-
Element Materials Technology Iowa City Inc. UEI GAJDDSFFPD89
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,311
Award facts
- Opportunity
-
- RFPNIAIDDMIDNIHAI2017091 Solicitation number
- In Vitro Assessments of Antimicrobial Activity Award Notice · Posted Nov 14, 2017
- Contract value 100% obligated
- $14,311.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Liberty, IA 52317, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Other Administrative Action | $0 | |
| Definitize Change Order | $0 | |
| Original award | $14,311 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $14,311 firm fixed-price delivery order to Element Materials Technology Iowa City Inc., doing business as JMI Laboratories, on July 22, 2019. This task order, designated Task A06, requires JMI Laboratories to determine the in vitro minimum inhibitory concentration (MIC) of a candidate antimicrobial product against a panel of Listeria monocytogenes clinical isolates. The work will be performed in North Liberty, Iowa, with an ultimate completion date of November 30, 2019. This delivery order was issued under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite-delivery/indefinite-quantity contract vehicle and does not utilize a small business set-aside.
JMI Laboratories is a microbiology specialist company with deep expertise in antimicrobial resistance testing and drug discovery research. The firm regularly conducts in vitro assessments of antimicrobial activity and MIC assays for federal agencies, including NIAID, the Food and Drug Administration, and the National Institutes of Health. This task order represents routine work within the company's core competency of evaluating the antimicrobial properties of experimental pharmaceutical candidates, contributing to NIAID's mission of addressing critical public health challenges related to infectious diseases and antimicrobial resistance.
Quick answers
Who was awarded contract 75N93019F00132?
75N93019F00132 was awarded to Element Materials Technology Iowa City Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 22, 2019.
How much is contract 75N93019F00132 worth?
The government has obligated $14,311 on 75N93019F00132.
Is contract 75N93019F00132 an order under another contract?
Yes. 75N93019F00132 is a delivery order under 75N93019D00011, an indefinite delivery contract, on In Vitro Assessments of Antimicrobial Activity (IVAAA).
Was contract 75N93019F00132 competed?
The extent of competition for 75N93019F00132 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award